scispace - formally typeset
Search or ask a question
Author

Els Braeken

Bio: Els Braeken is an academic researcher from Thomas More College. The author has contributed to research in topics: Context (language use). The author has an hindex of 3, co-authored 3 publications receiving 43 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: Public domain and commercial in silico tools were compared for their performance in predicting the skin sensitization potential of chemicals, with positive and negative predictive values up to 80% and 84%, respectively.
Abstract: Public domain and commercial in silico tools were compared for their performance in predicting the skin sensitization potential of chemicals. The packages were either statistical based (Vega, CASE ...

22 citations

Journal ArticleDOI
TL;DR: A new prioritization strategy for identifying potentially mutagenic substances was developed based on the combination of multiple (quantitative) structure-activity relationship ((Q)SAR) tools and can easily be applied to other groups of chemicals facing the same need for priority ranking.

21 citations

Journal ArticleDOI
TL;DR: Although the use of these models as stand-alone evaluation is not recommended, these models can be of value as weight-of-evidence in the context of expert knowledge in an Integrated Approach to Testing and Assessment.

16 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: This research presents a novel probabilistic procedure called “spot-spot analysis” that allows for real-time analysis of the response of the immune system to Epstein-Barr virus.
Abstract: During drug development, safety is always the most important issue, including a variety of toxicities and adverse drug effects, which should be evaluated in preclinical and clinical trial phases. This review article at first simply introduced the computational methods used in prediction of chemical toxicity for drug design, including machine learning methods and structural alerts. Machine learning methods have been widely applied in qualitative classification and quantitative regression studies, while structural alerts can be regarded as a complementary tool for lead optimization. The emphasis of this article was put on the recent progress of predictive models built for various toxicities. Available databases and web servers were also provided. Though the methods and models are very helpful for drug design, there are still some challenges and limitations to be improved for drug safety assessment in the future.

144 citations

Journal ArticleDOI
Glenn J. Myatt, Ernst Ahlberg1, Yumi Akahori, David Allen2, Alexander Amberg, Lennart T. Anger, Aynur O. Aptula, Scott S. Auerbach3, Lisa Beilke, Phillip Bellion4, Romualdo Benigni, Joel P. Bercu, Ewan D. Booth5, Dave Bower, Alessandro Brigo6, Natalie Burden, Zoryana Cammerer7, Mark T. D. Cronin8, Kevin P. Cross, Laura Custer9, Magdalena Dettwiler, Krista L. Dobo10, Kevin A. Ford, Marie C. Fortin11, Samantha E. Gad-McDonald, Nichola Gellatly, Véronique Gervais, Kyle P. Glover12, Susanne Glowienke13, Jacky Van Gompel14, Steve Gutsell, Barry Hardy, James Harvey15, Jedd Hillegass9, Masamitsu Honma, Jui-Hua Hsieh2, Chia Wen Hsu16, K. Hughes17, Candice Y. Johnson, Robert A. Jolly18, David Jones19, Ray Kemper20, Michelle O. Kenyon10, Marlene T. Kim16, Naomi L. Kruhlak16, Sunil Kulkarni17, Klaus Kümmerer21, Penny Leavitt9, Bernhard Majer22, Scott A. Masten3, Scott Miller, Janet Moser23, Moiz Mumtaz24, Wolfgang Muster6, Louise Neilson25, Tudor I. Oprea26, Grace Patlewicz27, Alexandre Paulino, Elena Lo Piparo28, Mark Powley16, Donald P. Quigley, M. Vijayaraj Reddy29, Andrea Richarz, Patricia Ruiz24, Benoît Schilter28, Rositsa Serafimova30, Wendy Simpson, Lidiya Stavitskaya16, Reinhard Stidl22, Diana Suarez-Rodriguez, David T. Szabo, Andrew Teasdale1, Alejandra Trejo-Martin, Jean Pierre Valentin, Anna Vuorinen4, Brian A. Wall31, Pete Watts, Angela White15, Joerg Wichard32, Kristine L. Witt3, Adam Woolley, David Woolley, Craig Zwickl, Catrin Hasselgren 
TL;DR: The publication presents a novel approach for determining the reliability of in silico predictions alongside experimental data and discusses how to determine the level of confidence in the assessment based on the relevance and reliability of the information.

123 citations

Journal ArticleDOI
TL;DR: A systematic classification and description of the databases and software commonly used for ADMET prediction and some applications that are related to the prediction categories and web tools are listed.
Abstract: Because undesirable pharmacokinetics and toxicity are significant reasons for the failure of drug development in the costly late stage, it has been widely recognized that drug ADMET properties should be considered as early as possible to reduce failure rates in the clinical phase of drug discovery. Concurrently, drug recalls have become increasingly common in recent years, prompting pharmaceutical companies to increase attention toward the safety evaluation of preclinical drugs. In vitro and in vivo drug evaluation techniques are currently more mature in preclinical applications, but these technologies are costly. In recent years, with the rapid development of computer science, in silico technology has been widely used to evaluate the relevant properties of drugs in the preclinical stage and has produced many software programs and in silico models, further promoting the study of ADMET in vitro. In this review, we first introduce the two ADMET prediction categories (molecular modeling and data modeling). Then, we perform a systematic classification and description of the databases and software commonly used for ADMET prediction. We focus on some widely studied ADMT properties as well as PBPK simulation, and we list some applications that are related to the prediction categories and web tools. Finally, we discuss challenges and limitations in the preclinical area and propose some suggestions and prospects for the future.

91 citations

Journal ArticleDOI
TL;DR: This analysis prioritized 608 hazardous FCCs for further assessment and substitution in FCMs/FCAs and explored FCCdb chemicals' hazards using several authoritative sources of hazard information, including classifications for health and environmental hazards under the globally harmonized system for classification and labeling of chemicals.

46 citations

Journal ArticleDOI
TL;DR: Current approaches for the detection and identification of NIAS from paper and board FCM are presented and future research is required into the selection of bioassays since these should be sensitive enough for detecting all compounds of concern but should also have a relevance with human health.
Abstract: Background Food contact materials (FCM) may contain non-intentionally added substances (NIAS) as a result of reaction by-products, oligomers, degradation processes, chemical reactions between packaging materials and foodstuff, or as impurities from the raw materials used for their production. Scope and approach In this review, current approaches for the detection and identification of NIAS from paper and board FCM are presented. Reviewed are the definition of NIAS, approaches for NIAS identification and quantification, the comprehensive analysis of NIAS and the role of in silico tools and bioassays. Key Findings and Conclusions NIAS in paper and board are mostly components from printing inks, adhesives, sizing agents and surface coatings. Recycled paper contains overall more NIAS than fresh paper. Targeted analysis is generally performed for predicted NIAS, whereas an untargeted, or full-scan screening method is applied to detect and identify unpredicted NIAS. Sample preparation and contact conditions fall in two categories; migration and extraction. Migration studies are performed with food simulants while extraction studies are Soxhlet or ultrasound assisted solvent extraction. In untargeted analysis in silico tools are gaining importance in the identification of NIAS. Bioassays are used to determine the bioactivity of extracts or fractions in order to assess the potential toxicity of NIAS present in the mixture. A combination of bioassays and chemical analysis is used to direct the identification of unknown bioactive NIAS in complex mixtures like those from paper and board FCM. However, future research is required into the selection of bioassays since these should not only be sensitive enough for detecting all compounds of concern but should also have a relevance with human health.

41 citations